Tusamitamab 是一种靶向CEACAM5的 IgG1 单克隆抗体。Tusamitamab 可用于合成 Tusamitamab ravtansine (SAR408701)，Tusamitamab ravtansine 是首创的人源化抗体药物偶联物 (ADC)，结合了 Tusamitamab 和 DM4 (一种强效美登素衍生物)。
| 生物活性 | Tusamitamab is anIgG1monoclonal antibody that targetsCEACAM5. Tusamitamab can be used to synthesize Tusamitamab ravtansine (SAR408701), which is a first-in-class humanized antibody-drug conjugate (ADC) that combines Tusamitamab and DM4 (a potent maytansine derivative)[1]. |
| Clinical Trial | |
| 性状 | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
